REGENXBIO
REGENX Biosciences is a biopharmaceutical company that develops therapeutics and research tools based on adeno-associated viral (AAV) vectors. The company offers NAV, a gene delivery technology that includes recombinant adeno-associated viral vectors. Its technology is used for the treatment of metabolic disorders, muscle diseases, hematologic disorders, ocular diseases, and neurodegenerative disorders; and clinical trails in therapeutic areas, such as inherited diseases, CNS disorders, heart fa... ilure, and vaccines. The company also offers reagent services for various applications, including molecular therapies, understanding biological activity, and target validation, creating disease models and screening in vivo, and genome-wide association studies. In addition, it offers custom products and services, including AAV plasmids, AAV Vector reporter systems, and custom AAV vectors to the researchers. The company is based in Washington, District Of Columbia.
REGENXBIO
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2009-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.regenxbio.com
Total Employee:
251+
Status:
Active
Contact:
(202) 785-7438
Total Funding:
638.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Current Advisors List
Board_member
2018-05-01
Board_member
Current Employees Featured
Kenneth Mills Chief Executive Officer, President and Director @ REGENXBIO
Chief Executive Officer, President and Director
2009-02-01
Ken Mills President & Chief Executive Officer @ REGENXBIO
President & Chief Executive Officer
Vit Vasista CFO @ REGENXBIO
CFO
2009-07-01
Curran M. Simpson Senior Vice President of Product Development & Chief Technology Officer @ REGENXBIO
Senior Vice President of Product Development & Chief Technology Officer
Olivier Danos Senior Vice President & Chief Scientific Officer @ REGENXBIO
Senior Vice President & Chief Scientific Officer
Steve Pakola Senior Vice President & Chief Medical Officer @ REGENXBIO
Senior Vice President & Chief Medical Officer
Francesca Cook Vice President, Market Access @ REGENXBIO
Vice President, Market Access
2021-03-01
Ram Palanki Senior Vice President, Commercial Strategy & Operations @ REGENXBIO
Senior Vice President, Commercial Strategy & Operations
2018-08-01
James M. Wilson Founder & Chief Scientific Advisor @ REGENXBIO
Founder & Chief Scientific Advisor
Olivier Danos Chief Scientific Officer @ REGENXBIO
Chief Scientific Officer
2017-03-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-25 | Dimension Therapeutics | Dimension Therapeutics acquired by REGENXBIO | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - REGENXBIO
RTW Investments LLC
RTW Investments LLC investment in Series D - REGENXBIO
Foresite Capital
Foresite Capital investment in Series D - REGENXBIO
Perceptive Advisors
Perceptive Advisors investment in Series D - REGENXBIO
Sectoral Asset Management
Sectoral Asset Management investment in Series D - REGENXBIO
Venrock
Venrock investment in Series D - REGENXBIO
Cormorant Asset Management
Cormorant Asset Management investment in Series D - REGENXBIO
QVT Financial
QVT Financial investment in Series D - REGENXBIO
F-Prime Capital
F-Prime Capital investment in Series D - REGENXBIO
Tourbillon Global Ventures
Tourbillon Global Ventures investment in Series D - REGENXBIO
Official Site Inspections
http://www.regenxbio.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.31 K
- Host name: 20.231.205.235
- IP address: 20.231.205.235
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
